Cost-Sharing as a Financing Mechanism in the Greek Primary Health Care: An Assessment from the Managers’ Perspective

Eleni G. Stokou¹, Athanassios Vozikis^2, and Gregory P. Chondrocoukis³

¹Nursing Department, Athens University, Athens, Greece

²Economics Department, University of Piraeus, Piraeus, Greece

³Department of Industrial Management, University of Piraeus, Piraeus, Greece

Cite this paper:
Eleni G. Stokou, Athanassios Vozikis and Gregory P. Chondrocoukis. Cost-Sharing as a Financing Mechanism in the Greek Primary Health Care: An Assessment from the Managers’ Perspective. Journal of Finance and Economics. 2013; 1(1):11-16. doi: 10.12691/jfe-1-1-3

Abstract

Cost-sharing was recently introduced in the Greek Primary Health Care, as a supplementary mechanism to finance spiraling health expenditure and to make patients cost-conscious.A specific questionnaire was distributed to the 188 managers of the health centres in Greece (response rate 93 per cent). The research was conducted from June 2011 to May 2012. Statistical analysis was performed using the Pearson x² test, the Kolmogorov-Smirnov test, the t-test and the Mann-Whitney test at p<0.05 level of significance. 73 per cent of the managers stated that the introduction of the cost-sharing had a positive impact on patients’ compliance and 66.3 per cent that the financing mechanism has contributed to cost consciousness from both the patients and personnel. The revenues from medical fees do not cover the running costs of health centres (81.5 per cent) and they do not promote a more effective delivery of services (80 per cent). 61 per cent of managers characterise cost-sharing as a positive step and 80 per cent support the economic autonomy of health centres.Managers stated that cost-sharing has a positive impact on patients’ cost-consciousness and in the financing of the primary health care in Greece, but this policy option alone doesn’t assure the financial and administrative viability of the health centres.

Keywords:
Greek primary health care health centres cost-sharing health care financing managers

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	OECD, Statistics: Demography, Old age support ratio, Available: http://www.oecd.org/document/0,3746,en_2649_201185_46462759_1_1_1_1,00.html, accessed 20 September 2012.
[2]	O’Reilly, D., O’Neill, C., O’Dowd, T., Galway, K., Gilliland, A., Kelly, A., Murphy, A., Shryane, E., Steele, K., Bury, G., “Patients’ attitudes to co-payments for general practitioner services: do they reflect the prevailing system”, Journal of Health Services Research and Policy, 12 (4). 2007.
[3]	Tambor M., Pavlova M., Woch P., Groot W., “Diversity and dynamics of patient cost-sharing for physicians’ and hospital services in the 27 European Union countries”, European Journal of Public Health, Oxford University Press, 21(5). 585-590. 2010.
[4]	Bolin, K., Lindgren, A., Lindgren, B., Lundborg B., “Utilization of physician services in the 501 population: the relative importance of individual versus institutional factors in 10 European countries”, International Journal of Health Care Finance and Economics, 9 (1). 83-112. 2009.
[5]	Wagner, T., Heisler, M., Piette, J., “Prescription drug co-payments and cost-related medication underuse”, Health Economics, Policy and Law, 3 (1). 51-67. 2008.
[6]	Rice, T., Matsuoka, K.Y., “The impact of cost-sharing on appropriate utilization and health status: a review of the literature on seniors”, Medical Care Research and Review, 61 (415). 2004.
[7]	Hurst S. A., Danis M., “Indecent Coverage? Protecting the Goals of Health Insurance from the Impact of Co-Payments”, Cambridge Quarterly of Healthcare Ethics, Cambridge University Press, 15. 107-113. 2006.
[8]	Weale A., Clark S., “Co-payments in t he NHS: an analysis of the normative arguments”, Health Economics, Policy and Law, Gambridge University Press, 5(2). 225-246. 2010.
[9]	Rui S., Changhoon J., “Does user-charge financing reduce expenditure levels for the charge-financed services?”, The American Review of Public Administration, SAGE, 42(2). 170-185. 2012.
[10]	Gemmill, M. C., Thomson, S., Mossialos, E., “What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries”, International Journal for Equity in Health, 7 (12). 2008.
[11]	Robinson, R., User charges for health care, in E. Mossialos, A. Dixon, J. Figueras, J. Kutzin (Eds), Funding health care: options for Europe, European Observatory on Health Care System Series, Buckingham-Philadelphia, 161-183, 2002.
[12]	Hassell K., Atella V., Schafheutle E., Weiss M., Noyce P., “Cost to the patient or cost to the healthcare system? Which one matters the most for GP prescribing decisions? A UK-Italy comparison.”, European Journal of Public Health, 13. 18-23. 2003.
[13]	Mossialos, E., Le Grand, J., Health Care and Cost Containment in the European Union, Ashgate Publishing Limited, Aldershot, 1999.
[14]	Reichmann, G., Sommersguter-Reichmann, M., “Co-payments in the Austrian social health insurance system. Analysing patient behavior and patients’ views on the effects of co-payments”, Health Policy, 67. 75-91. 2004.
[15]	McPake B., Brikci N., Cometto G., Schmidt A., Araujo E., “Removing user fees: learning from international experience to support the process”, Health Policy and Planning, Oxford University Press, 26. 104-117. 2011.
[16]	Rostermundt A., Westphal R., Raspe H., “Relevance and financing of health services: a survey of physicians, students, patients, nursing personnel and seniors”, Gesundheitswesen, 63(5). 311-318. 2001.
[17]	Wranik, D., “Healthcare policy tools as determinants of health system efficiency: evidence from the OECD”, Health Economics, Policy and Law, 7. 197-226. 2012.
[18]	OECD-Eurostat-WHO Health Accounts (SHA) Data Collection - (JHAQ) and OECD Health Data questionnaire, Health Expenditure and Financing. Available: http://stats.oecd.org/Index.aspx?DataSetCode=SHA#, accessed 4 September 2012.
[19]	WHO Statistics – Health Financing: Health Expenditure Ratios - Private expenditure on health as a percentage of total expenditure on health. Available: http://apps.who.int/minerva/minerva.jsp?theme=main&vid=1901D, accessed 18 September 2012.
[20]	Siskou, O., Kaitelidou, D., Papakonstantinou, V., Liaropoulos, L., “Private health expenditure in the Greek health care system: Where truth ends and the myth begins”, Health Policy, 88. 282-293. 2008.
[21]	Rezayatmand, R., Pavlova, M., Groot, W., “The impact of out of pocket payments on prevention and health related lifestyle: a systematic literature review”, The European Journal of Public Health Advance, 2012.
[22]	Kentikelenis, A., Karanikolos, M., Papanicolas, I., Basu, S., McKee, M., Stuckler, D., “Health effects of financial crisis: omens of a Greek tragedy”, Lancet, 378. 1457-1458. 2011.
[23]	Kentikelenis, A., Karanikolos, M., Papanicolas, I., Basu, S., McKee, M., Stuckler, D., “Health and the financial crisis in Greece”, Lancet, 379. 1002. 2012.
[24]	Greek Health Ministry, Report analysis of Health Ministry and NHS units of 2011, http://www.yyka.gov.gr/articles/hlektronikes...e-s.../1332-ethsia-ekthesh-2011?, accessed 1 February 2013.
[25]	Kyriopoulos J., Tsiantou V., “The financial crisis and its impact on health and medical care”, Archives of Hellenic Medicine, 27 (5). 834-840. 2010.
[26]	Anagnostopoulou, I., Semertziadi, M., Siskou, O., Kaitelidou, D., Tsounias, V., “Investigation of the intent of patients to participate in the cost in the health centre of Atalante”, Archives of Hellenic Medicine, 28 (6). 777-84. 2011.
[27]	Sepehri A., Chernomas R., Akram-Lodhi H., “Penalizing patients and rewarding providers: user charges and health care utilization in Vietnam”, Health Policy and Planning, Oxford University Press, 20(2). 90-99. 2005.
[28]	Fendrick, A. M., Smith, D. G., Chernew, M., Shah, S. N., “A benefit-based copay for prescription drugs: Patient contribution based on total benefits, not drug acquisition cost”, American Journal of Managed Care, 7 (9). 861-867. 2001.
[29]	Trottmann, M., Zweifel, P., Beck, K., “Supply-side and demand-side cost-sharing in deregulated social health insurance: Which is more effective?”, Journal of Health Economics, 31. 231-242. 2012.
[30]	Lionis C., Wynn-Jones J., “Establishing academic rural practice: a future and challenging target”, Rural and Remote Health 7(727). 2007.
[31]	Pauly M., “Market power, Monopsony and Health Insurance Markets”, Journal of Health Economics, 7. 111-128. 1988.
[32]	Pauly M., “Health Insurance and Market Failure in the Medical Economy”, Journal of Economic Literature, 15. 629-675. 1986.
[33]	33) Stuckler D, Basu S, Suhrcke M, Coutts A, McKee M. “The public health effect of economic crisis and alternative policy responses in Europe: An empirical analysis”. Lancet, 374. 315-323. 2009.